SARS-CoV-2 Spike RBD (receptor binding domain) 336-347
  1. Home
  2. Peptides
  3. Others
  4. SARS-CoV-2 Spike RBD (receptor binding domain) 336-347
Need Assistance?
  • US & Canada:
    +
  • UK: +

SARS-CoV-2 Spike RBD (receptor binding domain) 336-347

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

SARS-CoV-2 Spike RBD (receptor binding domain) 336-347 is the 336-347 amino acid residue of SARS-CoV-2 Spike RBD (receptor binding domain), which can recognize and bind to angiotensin-converting enzyme 2 (ACE2) receptor. SARS-CoV-2 Spike RBD has the potential to be developed as therapeutics and prophylactics against SARS-CoV-2.

Category
Others
Catalog number
BAT-016903
Molecular Formula
C64H90N16O17S
Molecular Weight
1387.62
SARS-CoV-2 Spike RBD (receptor binding domain) 336-347
Synonyms
H-Cys-Pro-Phe-Gly-Glu-Val-Phe-Asn-Ala-Thr-Arg-Phe-OH; Cys-Pro-Phe-Gly-Glu-Val-Phe-Asn-Ala-Thr-Arg-Phe
Appearance
White powder
Sequence
CPFGEVFNATRF
Storage
Store at -20 °C
Related Products
Semaxinib
Semaxinib

CAT NO. : BAT-008962
N-(gamma-Glutamyl)ethanolamine
N-(gamma-Glutamyl)ethanolamine

CAT NO. : BAT-014378
COG 133
COG 133

CAT NO. : BAT-006089
Cyclo(Pro-Trp)
Cyclo(Pro-Trp)

CAT NO. : BAT-006245
HMHA-Gln
HMHA-Gln

CAT NO. : BAT-008575
BKT140
BKT140

CAT NO. : BAT-006144
Online Inquiry
Inquiry Basket
Loading ......
Delete selectedGo to checkout